Heyholder
‹ Activism Filings

UTI INC. Q3 revenue KRW 7.0 billion, operating loss KRW 14.5 billion

UTI INC.· Periodic Report

AI summary · Not investment advice

UTI sold KRW 7.0 billion worth in Q3 but lost KRW 14.5 billion from its main business, versus a KRW 13.3 billion loss a year earlier.

Operating profit · 3 months

KRW -14.5 billion

Key facts

Revenue (3 months)
KRW 7.0 billion
Net income (3 months)
KRW -20.7 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 4.6 billion
Revenue (year to date)
KRW 17.2 billion
Operating profit (prior-year 3 months)
KRW -13.3 billion
Operating profit (year to date)
KRW -43.6 billion
Net income (prior-year 3 months)
KRW -15.9 billion
Net income (year to date)
KRW -22.0 billion

Commentary

AI commentary · Not investment advice

What happened

UTI reported its consolidated results for the 3rd quarter, with figures also shown cumulatively for January to September, in a quarterly report. Sales for the 3 months were KRW 6.97 billion. That is 51.0% more than the same 3 months a year earlier (KRW 4.62 billion) and 26.9% more than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 14.53 billion. A year earlier, the same period showed a loss of KRW 13.30 billion. Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 20.75 billion. The previous quarter was not a loss, so this marks a swing to a loss. A year earlier, the same period showed a loss of KRW 15.94 billion.

What changes for shareholders

For the year to date, sales are KRW 17.24 billion. Operating profit is a loss of KRW 43.60 billion. Net income is a loss of KRW 22.01 billion.

Comments

No comments yet

Comments from shareholders will appear here.